MedTrace Logo

Study to Examine the Safety, Tolerability, and Pharmacokinetics of AV650

NCT00364039 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2007-02-28

No results posted yet for this study

Summary

The purpose of this study is to determine the safety and tolerability of AV650 in healthy subjects given single and multi-doses under fasted and fed conditions.

Conditions

  • Healthy Subjects

Interventions

DRUG

AV650

Sponsors & Collaborators

  • Avigen

    lead INDUSTRY

Principal Investigators

  • Stephan A. Bart, M.D. · SNBL Clinical Pharmacology Center

Study Design

Allocation
RANDOMIZED
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00364039 on ClinicalTrials.gov